Literature DB >> 8517591

Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity.

S Hayasaka1, S Ugomori, T Kodama, S Noda, T Setogawa.   

Abstract

A 69-year-old man (Patient 1) complained of anorexia, lumbago, and seeing floaters OS. The results of laboratory tests showed immunoglobulin (Ig) G lambda-type multiple myeloma associated with blood hyperviscosity. Retinal hemorrhages OD and central retinal vein occlusion OS were found. A 71-year-old woman (Patient 2) with IgG kappa-type multiple myeloma had blood hyperviscosity. Retinal microaneurysms OD and central retinal vein occlusion OS were found. We believe that our patients represent rare cases of IgG multiple myeloma associated with blood hyperviscosity and central retinal vein occlusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517591

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  4 in total

1.  Paraproteinemia and central retinal vein occlusion.

Authors:  E I Agorogiannis; V Kotamarthi
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

2.  Ophthalmic manifestations of atypical IgD multiple myeloma.

Authors:  Matthew R Edmunds; Peter Cikatricis; Subhanjan Mukherji; Jeremy D Bowyer
Journal:  BMJ Case Rep       Date:  2012-07-19

3.  Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion.

Authors:  Paola Ferrazzi; Pierpaolo Di Micco; Ilaria Quaglia; Lisa Simona Rossi; Alessandro Giacco Bellatorre; Giorgio Gaspari; Lidia Luciana Rota; Corrado Lodigiani
Journal:  Thromb J       Date:  2005-09-07

4.  Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma.

Authors:  Natasha Ferreira Santos da Cruz; José Arthur Pinto Milhomens Filho; Desirée Mayara Nery Ferraro; Murilo Ubukata Polizelli; Nilva Simeren Bueno de Moraes Ambrogini
Journal:  Case Rep Ophthalmol       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.